Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

While showing off the map, players picked up on the first look at an upcoming hero: Blade. Previous leaks suggested that Blade would arrive in Marvel Rivals’ Season 2. This would make sense ...

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158. ...

The official added that while China is already trying to fill certain voids left by the U.S., it’s unclear whether they will fund programs focused on women. The White House has accused USAID of ...

Stellar Blade developer Shift Up expects the forthcoming PC release of its action game to exceed sales of the console release. As part of its latest financial report, the company was asked about ...

In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...

The White House slammed Democratic Sen. Chris Murphy as a "moron" on social media after the Connecticut lawmaker posted an expletive-riddled admonishment against a Lara Trump parody account he ...

“They were left up there for political reasons, which is not good,” the world’s richest man said while seated next to President Trump in a joint interview with Fox News’ Sean Hannity on ...